Prediction of Survival in Patients with Unresectable Colorectal Liver Metastases
Journal Title: Polish Journal of Surgery - Year 2014, Vol 86, Issue 7
Abstract
Liver metastases are diagnosed synchronously with the primary tumour in 25% of patients with colorectal cancer. A half of the remaining patients develop liver metastases within 3 years following colectomy. At present, the only radical treatment of metastases is liver resection. Only 2.6% of patients survive 3 years if such treatment is not implemented. The aim of the study was to assess predictive factors of long-term survival in the group of patients with unresectable colorectal liver metastases carcinoma. Material and methods. Of 1029 patients with colorectal liver metastases, who were treated in the Department of General, Transplant and Liver Surgery of the Medical University of Warsaw in the years 2006-2012, cases of liver metastases assessed intraoperatively as unresectable were selected. The retrospective analysis included 85 patients. Based on the medical documentation, information concerning age, sex, characteristics of primary and secondary tumours, reasons for unresectability, neoadjuvant chemotherapy as well as local treatment of liver tumours was collected. Preoperative serum concentrations of CEA and CA 19-9 markers were considered. The Cox regression model, KaplanMeier estimator and log-rank test were applied in the statistical analyses. Results. The most common reason for unresectability were: number of metastases in 31 patients (36.5%) and extrahepatic metastases in 19 cases (22.4%). Overall survival in the entire group was 56.1% and 15.5% after 1 and 3 years respectively. A single-factor analysis showed that CEA serum levels (p=0.032; HR=1.002 per increase by 1 ng/ml) and the presence of extrahepatic metastases (p=0.037; HR=2.06) were predictors of worse survival. In a multivariate analysis, CEA concentration (p=0.017; HR=1.002 per increase by 1 ng/ml) was an independent predictor of death whereas the presence of extrahepatic metastases were not statistically significant (p=0.059; HR=2.09). Conclusions. Serum concentration of CEA marker is an independent predictor of worse survival, but the presence of extrahepatic metastases shows a similar tendency.
Authors and Affiliations
Wacław Hołówko, Michał Grąt, Barbara Hinderer, Izabela Orlińska, Marek Krawczyk
Keywords
Related Articles
- EP ID EP74419
- DOI 10.2478/pjs-2014-0056
- Views 126
- Downloads 0
Zmiana podejścia do laparoskopowych operacji przepuklin brzusznych sposobem IPOM – czego nauczyła nas ostatnia dekada?
-
Kompleksowe omówienie pierwotnego zapalenia gruźliczego pęcherzyka żółciowego
Gruźlica (TB) jest chorobą zakaźną, która może wpływać na każdy z narządów w organizmie człowieka. Gruźlica brzuszna może przyjąć formę zapalenia żołądkowo-jelitowego, zapalenia węzłów chłonnych, zapalenia trzewnej lub o...
Efficacy of Possum Score in Predicting the Outcome in Patients Undergoing Emergency Laparotomy
Monitoring of surgical outcome is increasingly important part of governance of surgical activity. The aim of the study. POSSUM scoring system was applied prospectively to determine how it performed in predicting morbidit...
VAAFT: a new minimally invasive method in the diagnostics and treatment of anal fistulas – initial results
The aim of the study was to present our own experience in the treatment of anal fistulas by means of VAAFT (Video-Assisted Anal Fistula Treatment). Material and methods. Twenty patients were qualified for the VAAFT proce...
Rak jasnokomórkowy w obrębie ściany jamy brzusznej
Wprowadzenie: Rak jasnokomórkowy, wywodzący się z blizny po cięciu cesarskim, jest niezwykle rzadki. W piśmiennictwie opisano tylko 22 przypadki tego nowotworu, stąd strategie jego leczenia wymagają dalszego opracowania....